Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/43041
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Naranjo, Antonio | |
dc.contributor.author | Ojeda-Bruno, Soledad | |
dc.contributor.author | Bilbao Cantarero, Ana | |
dc.contributor.author | Quevedo Abeledo, Juan Carlos | |
dc.contributor.author | Henríquez-Hernández, Luis Alberto | |
dc.contributor.author | Rodríguez-Lozano, Carlos | |
dc.contributor.other | Naranjo Hernandez, Antonio | |
dc.contributor.other | Henriquez-Hernandez, Luis Alberto | |
dc.date.accessioned | 2018-11-21T12:13:22Z | - |
dc.date.available | 2018-11-21T12:13:22Z | - |
dc.date.issued | 2014 | |
dc.identifier.issn | 1699-258X | |
dc.identifier.uri | http://hdl.handle.net/10553/43041 | - |
dc.description.abstract | Objective: To assess the influence of the implementation of a program for secondary prevention of osteoporotic fractures on prescribing bisphosphonates and persistent short-term treatment. Patients and methods: Patients >. 50 years with fragility fracture attended in the emergency department were enrolled in an observational study. The program consisted of: 1) training of primary care physicians, 2) baseline visit: questionnaire on osteoporosis, bone densitometry and patient education, 3) patient referral to primary care, except those with multiple fractures or requiring special study or therapy, who were referred to a specialist, and 4) follow-up by checking prescriptions in electronic records, and a telephone survey. The outcome variable was the percentage of patients who, on having been prescribed bisphosphonates, still adhered to the treatment at 3 months. Results: Of the 532 patients with inclusion criteria, 202 (39%) refused to participate. Those who refused to take part had a higher mean age (P<. .01) and a higher frequency of hip fracture (P<. .01) compared with patients who did participate. A total of 330 patients were included for intervention, with a mean age of 71 years, and 254(77%) were female. An antiresorptive was being used by 45 patients (13%) at baseline. After the baseline visit 223 patients (67%) were recommended a bisphosphonate. In the follow-up at 3 months 78% of patients who had been prescribed bisphosphonate were still receiving treatment. Conclusions: We present a multidisciplinary program for secondary prevention of fractures coordinated by rheumatology in which the number of patients who were receiving bisphosphonate at 3 months increased by four times compared to baseline visit. © 2013 Elsevier España, S.L.U. | |
dc.publisher | 1699-258X | |
dc.relation.ispartof | Reumatologia Clinica | |
dc.source | Reumatologia Clinica[ISSN 1699-258X],v. 10 (5), p. 299-303 | |
dc.title | Results of a model of secondary prevention for osteoporotic fracture coordinated by rheumatology and focused on the nurse and primary care physicians | |
dc.type | info:eu-repo/semantics/Article | es |
dc.type | Article | es |
dc.identifier.doi | 10.1016/j.reuma.2013.12.007 | |
dc.identifier.scopus | 84906790010 | - |
dc.identifier.isi | 000421428100006 | |
dcterms.isPartOf | Reumatologia Clinica | |
dcterms.source | Reumatologia Clinica[ISSN 1699-258X],v. 10 (5), p. 299-303 | |
dc.contributor.authorscopusid | 7003297397 | |
dc.contributor.authorscopusid | 6602428868 | |
dc.contributor.authorscopusid | 7801311085 | |
dc.contributor.authorscopusid | 55295814500 | |
dc.contributor.authorscopusid | 15829708200 | |
dc.contributor.authorscopusid | 6603136298 | |
dc.description.lastpage | 303 | |
dc.description.firstpage | 299 | |
dc.relation.volume | 10 | |
dc.type2 | Artículo | es |
dc.identifier.wos | WOS:000421428100006 | |
dc.contributor.daisngid | 550893 | |
dc.contributor.daisngid | 4801071 | |
dc.contributor.daisngid | 8143522 | |
dc.contributor.daisngid | 7862165 | |
dc.contributor.daisngid | 465624 | |
dc.contributor.daisngid | 1048977 | |
dc.identifier.investigatorRID | E-7910-2010 | |
dc.identifier.investigatorRID | No ID | |
dc.date.coverdate | Enero 2014 | |
dc.identifier.ulpgc | Sí | es |
dc.description.esci | ESCI | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Grupo de investigaciones infecciosas, nutricionales e inflamatorias en pacientes hospitalarios / Study Group on infectious, nutritional and inflammatory diseases in hospitalized patients | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
crisitem.author.dept | GIR IUIBS: Medio Ambiente y Salud | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.orcid | 0000-0002-2013-6664 | - |
crisitem.author.orcid | 0000-0003-3237-0316 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Naranjo Hernández, Antonio | - |
crisitem.author.fullName | Henríquez Hernández, Luis Alberto | - |
Colección: | Artículos |
Citas SCOPUSTM
21
actualizado el 17-nov-2024
Citas de WEB OF SCIENCETM
Citations
22
actualizado el 17-nov-2024
Visitas
31
actualizado el 08-jul-2023
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.